ORGANO (6368) FY2027 Q1 Earnings Report

Quick View

Executive Summary

The first quarter of the fiscal year ending March 2027 saw higher revenue but lower earnings, with the failure of revenue expansion to translate into profit growth being its most notable feature. Revenue was ¥421.8B (+10.7% YoY), Operating Income was ¥66.1B (-4.9%), Ordinary Income was ¥67.6B (+4.5%), and Net Income was ¥34.4B (-5.7%). Ordinary Income increased due to the recognition of foreign exchange gains, but Net Income was reduced more significantly than Operating Income due to the higher effective tax rate.

Factors Affecting Performance

【Revenue】Revenue increased 10.7% YoY to ¥421.8B. The core Water Treatment Engineering Business increased 8.8% (revenue mix: 82.8%), while the Functional Products Business increased 20.8% (17.2%), with both businesses contributing to the revenue increase. Although the growth rate of the Functional Products Business exceeded that of the core business, the Water Treatment Engineering Business continued to drive the overall business in terms of revenue scale.

【Profit and Loss】Operating Income decreased 4.9% YoY to ¥66.1B, and the Operating Income margin declined to 15.7% from 18.2% in the previous year, a decrease of 2.6pt. Profit margins declined in both the Water Treatment Engineering Business, from 19.0% to 16.3%, and the Functional Products Business, from 14.0% to 12.5%, indicating margin compression across both businesses. Ordinary Income increased 4.5% to ¥67.6B due to improved non-operating income and expenses, including a foreign exchange gain of ¥1.4B. However, Net Income was ¥34.4B (-5.7%) due to the high effective tax rate of 49.2%. No extraordinary gains or losses were recorded, and the heavy tax burden was the primary factor expanding the decline in Net Income beyond that of Operating Income. In conclusion, the results reflect higher revenue but lower earnings.

Segment Analysis

The Water Treatment Engineering Business posted Revenue of ¥349.2B (+8.8% YoY), Operating Income of ¥57.0B (-6.7%), and a profit margin of 16.3% (19.0% in the previous year). Although it is the core business, accounting for approximately 86% of consolidated Operating Income, its profitability deteriorated. The Functional Products Business posted Revenue of ¥73.6B (+20.6%), Operating Income of ¥9.1B (+7.9%), and a profit margin of 12.4% (14.0% in the previous year). While its revenue growth rate was high, its profit margin declined. Both businesses showed the common pattern of higher revenue accompanied by lower profit margins, suggesting that the effects of project mix and rising costs may be affecting the Company as a whole.

Key Financial Metrics

【Profitability】The Operating Income margin was 15.7%, down 2.6pt from 18.2% in the same period of the previous year, while the Net Income margin also declined from 8.1%. The effective tax rate was high at approximately 49%, reducing the conversion rate from Profit Before Tax to Net Income. 【Cash Flow Quality】Accounts receivable and notes receivable of ¥787.7B accounted for 35.5% of total assets, and, together with inventories of ¥85.4B, indicate a high level of working capital. The provision for product warranties of ¥13.7B represented 3.3% of Revenue, and trends in warranty-related costs could affect profitability. 【Investment Efficiency】ROE was 2.4% (on a cumulative quarterly basis), and EPS declined to ¥74.73 from ¥79.25 in the same period of the previous year. 【Financial Soundness】The Equity Ratio was high at 64.0%, and the Company held ¥278.4B in cash and deposits. Long-term borrowings remained limited at ¥60.0B, indicating a conservative financial foundation.

Cash Flow Analysis

Although a cash flow statement has not been disclosed, funding trends can be assessed from changes in the balance sheet. Cash and deposits were ¥278.4B, down from ¥310.6B at the end of the same period of the previous year. Meanwhile, accounts receivable and notes receivable remained high at ¥787.7B, suggesting that funds were tied up in trade receivables. Interest-bearing debt consisted primarily of short-term borrowings of ¥313.6B, with the cash coverage ratio remaining at approximately 0.9x. The Equity Ratio of 64.0% and current assets of ¥1,881.6B substantially exceeding current liabilities of ¥688.2B support the stability of the Company’s liquidity position.

Earnings Quality

The increase in Ordinary Income resulted from improved non-operating income and expenses, including a foreign exchange gain of ¥1.4B, which offset the decline in Operating Income. Accordingly, it is important to note that factors unrelated to core operating earnings contributed to the result. Non-operating income was limited to 0.6% of Revenue, indicating that the degree of reliance itself was limited. No extraordinary gains or losses were recorded, and the difference between Profit Before Tax and Net Income was primarily attributable to the high tax burden represented by the effective tax rate of 49.2%. This tax burden factor increased from the same period of the previous year, contributing to the divergence in direction between changes in Operating Income and Ordinary Income and changes in Net Income. Comprehensive Income was ¥37.6B, exceeding Net Income of ¥34.4B, with a foreign currency translation adjustment of ¥3.3B being the primary contributing factor.

Earnings Forecast and Guidance

The full-year plan calls for Revenue of ¥2,000.0B (+12.6% YoY), Operating Income of ¥400.0B (+6.2%), and Ordinary Income of ¥400.0B (+4.9%), with no revisions to the earnings forecast. The Q1 progress rates were 21.1% for Revenue, 16.5% for Operating Income, and 16.9% for Ordinary Income, all below the standard 25% level. Achieving the full-year plan will require a recovery in the Operating Income margin to approximately 21.2% during the remaining period, making profitability improvement centered on the Water Treatment Engineering Business the key to achieving the plan.

Shareholder Returns

A 1-for-5 stock split, effective October 1, 2026, is scheduled. Excluding the effects of the split, the projected annual dividend for the fiscal year ending March 2027 is ¥220 (previous-year dividend: ¥95). Estimating the total annual dividend before the split adjustment based on the number of shares outstanding results in approximately ¥102B, implying an estimated Payout Ratio of 34.0% against the full-year Net Income plan of ¥300.0B. Retained earnings were substantial at ¥1,195.2B, indicating sufficient accumulated resources for dividends.

Risk Factors

1. Declining profitability in the core business: The Water Treatment Engineering Business accounts for approximately 86% of consolidated Operating Income, but segment profit declined 6.7% YoY and its profit margin decreased from 19.0% to 16.3%. Project profitability in this business will have a significant impact on consolidated profitability.

2. High effective tax rate: The effective tax rate increased to 49.2% from the same period of the previous year, creating a structure in which increases in Profit Before Tax are less likely to translate into Net Income. Ordinary Income increased 4.5%, whereas Net Income declined 5.7%, resulting in a divergence in direction.

3. Working capital and warranty cost burden: Accounts receivable and notes receivable of ¥787.7B accounted for 35.5% of total assets, while the provision for product warranties was equivalent to 3.3% of Revenue. Longer collection cycles and rising warranty expenses could affect both capital efficiency and profitability.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Operating Income margin and Net Income margin exceeded the industry median, indicating that profitability was relatively high within the industry.

Growth and Capital Efficiency

The Revenue growth rate also exceeded the industry median, indicating a relatively rapid pace of revenue growth within the industry.

※Source: Company compilation

Key Takeaways from the Results

1. Although the Operating Income margin remained at 15.7%, above the industry median, it declined 2.6pt YoY. The failure of higher revenue to translate into profit growth was the primary change in these results.

2. The decline in the profit margin of the Water Treatment Engineering Business, which accounts for approximately 86% of consolidated Operating Income, was the central factor behind the decline in overall profitability. Trends in project profitability in this business will be a key area of focus going forward.

3. The Q1 progress rate against the full-year Operating Income plan was 16.5%, below the standard 25%. However, the earnings forecast was not revised, and the Company maintained its plan based on an earnings recovery in the second half.

Theoretical Stock Price (Reference Value)

Sensitivity: ¥2,607–¥2,759 at Cost of Equity ±1%, and ¥2,668–¥2,690 at ω ±0.1.

Notes:

• Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value Per Share.
• Net assets as of the end of the quarter are used (there is a timing difference relative to the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market stock price or a recommendation of any specific investment action, and it does not predict or guarantee future stock prices.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Organo delivered a solid top-line start to FY2027, although Q1 profit margins and attributable profit declined year on year. Revenue rose 10.7% year on year to ¥42.18bn, led by continued expansion in the Water Treatment Engineering business and stronger Functional Products sales. Operating income declined 4.9% to ¥6.61bn despite the higher revenue base. Gross profit increased 5.4% to ¥13.78bn, but it grew materially more slowly than revenue. The gross margin consequently fell to 32.7% from 34.5%, a 177bp contraction. SG&A expenses rose 16.1% to ¥7.17bn, exceeding revenue growth and causing operating margin to compress 258bp to 15.7%. The operating margin remains above the 15% benchmark for excellent profitability, but the direction of margin movement merits attention. Ordinary income nevertheless increased 4.5% to ¥6.76bn because non-operating results improved sharply. In particular, the company recorded a ¥0.14bn foreign-exchange gain, compared with a ¥0.48bn loss in the prior-year quarter. Profit before tax increased 3.8% to ¥6.76bn. Net income fell 5.7% to ¥3.44bn because the effective tax rate rose to 49.2% from approximately 44.0% a year earlier. The FY2027 full-year plan calls for revenue of ¥200.0bn and operating income of ¥40.0bn, implying Q1 progress of 21.1% and 16.5%, respectively. Both progress rates are below the standard 25% first-quarter run rate, particularly operating-profit progress, although the company’s project-oriented engineering business can have meaningful quarterly timing effects. The core Water Treatment Engineering business remained the principal earnings contributor, generating 86.2% of consolidated segment operating income. Balance-sheet liquidity is strong, with a 273.4% current ratio and ¥119.3bn of working capital. The principal financial operating issues are the high effective tax burden, long receivable collection cycle, elevated cash conversion cycle, heavy reliance on short-term borrowings, and warranty provisioning equivalent to 3.3% of quarterly revenue. Management’s ability to restore gross margin and contain SG&A while converting project receivables into cash will be central to assessing whether the full-year profit plan is achievable.

Profitability Analysis

The reported annualized ROE is 9.7%, decomposed into an 8.2% net profit margin, 0.761x annualized asset turnover, and 1.56x financial leverage. This indicates that returns are supported primarily by a healthy operating margin and efficient utilization of a relatively asset-light balance sheet rather than aggressive leverage. Financial leverage is moderate, with a D/E ratio of 0.56x, and does not represent a material amplification of shareholder-return risk. The most notable change in Q1 profitability was margin compression: gross margin declined 177bp and operating margin declined 258bp year on year. Revenue growth of 10.7% was insufficient to offset a 16.1% increase in SG&A expenses, demonstrating negative operating leverage in the quarter. Water Treatment Engineering recorded revenue growth of 8.8% to ¥34.92bn, while segment profit declined 6.7% to ¥5.70bn, reducing its segment margin to 16.3% from 19.0%. Functional Products grew faster, with revenue up 20.8% to ¥7.26bn and segment profit up 7.9% to ¥0.91bn, but its 12.5% segment margin remained below Water Treatment Engineering’s margin. The 5-factor DuPont tax burden was 0.508, substantially below the normal level of above 0.70, and was the main constraint on conversion of pre-tax earnings into net income. The interest burden of 1.023 reflects net non-operating income rather than debt-service strain; interest coverage remains very strong at 68.9x. Operating profit of ¥6.61bn and EBIT margin of 15.7% therefore remain robust in absolute terms, but the sustainability of this level depends on restoring cost discipline and project profitability.

Growth Assessment

Revenue growth was broad-based across both reported segments. Water Treatment Engineering added ¥2.82bn of revenue year on year, while Functional Products added ¥1.25bn. The Water Treatment Engineering business is the core business by operating-income contribution, producing ¥5.70bn of the consolidated ¥6.61bn segment operating profit. Functional Products provides a faster-growing but lower-margin complement, with Q1 sales growth of 20.8% versus 8.8% in Water Treatment Engineering. Consolidated gross profit growth of 5.4% lagged sales growth, indicating that growth carried lower incremental gross profitability in Q1. The full-year revenue forecast implies 12.6% growth, modestly above the Q1 growth rate, requiring an acceleration in revenue recognition over the remaining quarters. The full-year operating-income forecast of ¥40.0bn implies 6.2% growth, contrasting with the Q1 decline and requiring substantial margin recovery. Q1 operating-income progress of 16.5% is 8.5 percentage points below the standard 25% run rate, while revenue progress of 21.1% is 3.9 percentage points below it. The lack of a forecast revision leaves the original full-year targets in place, making subsequent project execution and margin normalization important. Foreign-exchange gains of ¥0.14bn supported ordinary income but are not a substitute for recovery in core operating profitability.

Financial Health

Liquidity is strong: current assets of ¥188.16bn exceed current liabilities of ¥68.82bn, resulting in a current ratio of 273.4% and a quick ratio of 261.0%. Working capital totals ¥119.33bn, providing a substantial buffer against ordinary operating fluctuations. Total equity of ¥141.89bn funds 64.0% of total assets, while total liabilities account for 36.0%, indicating a sound capital base. Interest-bearing debt totals ¥37.36bn, equivalent to 20.8% of total capital and 0.56x equity. These leverage measures are conservative relative to the 40% debt-to-capital and 1.0x D/E reference thresholds. Interest expense was only ¥0.96bn against ¥6.61bn of EBIT, supporting a strong 68.9x interest-coverage ratio. However, ¥31.36bn, or 83.9%, of interest-bearing debt is short term. This refinancing-risk flag is material because the short-term debt ratio is far above the 40% caution threshold and short-term loans exceed cash and deposits of ¥27.84bn, producing a cash-to-short-term-debt ratio of 0.89x. The maturity mismatch is mitigated by the large receivable balance, strong quick ratio, and substantial net working-capital position, but it increases sensitivity to collection timing and bank funding conditions. Defined-benefit liabilities of ¥4.72bn are a meaningful noncurrent obligation, although modest relative to total equity. No current-ratio or D/E warning is indicated.

Notable B/S Changes

Work in process: +¥1.16bn (+21.5% YoY) to ¥6.54bn - consistent with a larger project pipeline, but requires monitoring alongside the long collection cycle for potential execution-related cash absorption. Construction in progress: +¥0.22bn (+91.1% YoY) to ¥0.47bn - a small absolute balance but a sharp percentage increase, indicating a modest increase in the investment pipeline. Short-term loans: +¥2.96bn (+10.4% YoY) to ¥31.36bn - increased reliance on short-term funding while cash declined, heightening the importance of receivable collection and refinancing management.

Cash Flow Quality

The balance-sheet profile points to working-capital intensity as the principal cash-conversion issue. Trade receivables were ¥78.77bn and electronically recorded monetary claims were ¥4.81bn at quarter end, together representing a substantial portion of current assets. The reported annualized DSO is 170 days, well above the 60-day warning threshold. This high-receivable-days flag likely reflects the long billing and collection cycle inherent in large-scale water-treatment engineering projects, but it also increases exposure to customer acceptance, milestone timing, and delayed payment risk. The reported annualized cash conversion cycle is 178 days, above the 120-day warning threshold. A long cash conversion cycle is consistent with project-based manufacturing and engineering, yet it ties up funding and makes cash generation more sensitive to collection execution. Accounts payable declined 14.3% year on year to ¥17.10bn, while short-term loans increased 10.4% to ¥31.36bn, reinforcing the importance of working-capital funding discipline. Work in process increased 21.5% year on year to ¥6.54bn, which may reflect higher project activity but also warrants monitoring for execution delays or cost overruns. Finished goods were essentially stable year on year at ¥8.54bn, limiting evidence of broad finished-goods accumulation. Contract liabilities increased 11.2% to ¥3.91bn, providing some advance-funding support for projects. No extraordinary gains or losses were reported, so Q1 earnings were not dependent on disclosed exceptional items. Foreign-exchange gains of ¥0.14bn aided ordinary income but were small relative to operating income. The elevated collection cycle means that conversion of reported profit into cash should remain a key analytical focus.

Dividend Sustainability

The company has indicated a planned five-for-one stock split effective October 1, 2026. The stated FY2027 forecast equates to an annual dividend of ¥220 per pre-split share, or ¥44 on a post-split equivalent basis. Using forecast EPS implied by forecast net income and the current share count, the indicated dividend payout ratio is approximately 34%, which is below the 60% sustainability benchmark. This represents a moderate dividend commitment relative to expected earnings and retained earnings of ¥119.52bn. The company’s strong liquidity, conservative debt-to-capital ratio, and high interest coverage support financial capacity for dividends. The key constraint on dividend flexibility is not accounting profitability but the extended receivables and cash conversion cycle. Continued collection discipline and delivery of the ¥30.0bn full-year net-income plan would support the indicated distribution level.

Risk Assessment

Business risks include Project execution and margin risk: Water Treatment Engineering revenue rose 8.8%, but segment profit fell 6.7%, reducing its segment margin from 19.0% to 16.3%. As the core business, further cost overruns, unfavorable project mix, or delayed milestone recognition would have a material group impact., Working-capital and customer-collection risk: annualized DSO of 170 days and annualized cash conversion cycle of 178 days indicate substantial capital tied up in project receivables. This may be structurally common in engineering projects, but delayed customer acceptance or payments could pressure liquidity and increase reliance on short-term funding., Quality and warranty risk: product warranty provisions of ¥1.37bn equal 3.3% of quarterly revenue, exceeding the 3% warning threshold. This may reflect the long-term performance obligations associated with water-treatment systems, but elevated warranty costs can signal installation, product reliability, or contractual-service exposure., Industry-specific demand and procurement risk: water-treatment engineering demand depends on semiconductor, electronics, industrial, municipal, and overseas capital-investment activity. Project timing, customer capital-spending cycles, equipment procurement conditions, and construction labor availability can affect order execution and margins., Currency risk: Q1 included a ¥0.14bn foreign-exchange gain after a ¥0.48bn loss in the prior-year quarter, indicating that foreign-currency movements can affect ordinary income even though the Q1 impact was limited relative to operating profit..

Financial risks include Refinancing risk: 83.9% of interest-bearing debt is short term, far above the 40% caution threshold. The balance sheet is otherwise conservative, but funding continuity depends on bank facilities and timely working-capital conversion., Tax-conversion risk: the effective tax rate rose to 49.2%, producing a 0.508 tax burden and causing net income to decline despite higher pre-tax profit. Repetition of this elevated rate would constrain EPS growth., Funding sensitivity: cash and deposits of ¥27.84bn cover 0.89x short-term debt. Large liquid current assets mitigate this risk, but receivables are less immediately available than cash..

Key concerns include SG&A expenses increased 16.1%, faster than 10.7% revenue growth, driving a 258bp decline in operating margin., Q1 operating-income progress was 16.5% against the ¥40.0bn full-year plan, 8.5 percentage points below a standard 25% first-quarter pace., The combination of increased work in process, high receivable days, declining trade payables, and higher short-term loans should be monitored for project-related cash absorption..

Investment Implications

Key takeaways include Revenue momentum remains favorable, with consolidated sales up 10.7% and both operating segments expanding., Operating profitability remains high in absolute terms at a 15.7% margin, but Q1 showed clear gross-margin and SG&A pressure., Water Treatment Engineering remains the core earnings engine, contributing 86.2% of segment operating income, but its margin deterioration is the principal earnings issue., The balance sheet is well capitalized and liquid, with 64.0% equity/assets, a 273.4% current ratio, and 68.9x interest coverage., Receivable collection, short-term-debt management, warranty costs, and normalization of the effective tax rate are more important near-term variables than headline leverage..

Metrics to watch include Water Treatment Engineering segment margin and project cost performance, Consolidated gross margin and SG&A-to-sales ratio, Progress toward the ¥200.0bn revenue and ¥40.0bn operating-income forecasts, Annualized DSO of 170 days and annualized cash conversion cycle of 178 days, Short-term loan balance, cash-to-short-term-debt coverage, and funding maturity profile, Warranty provision relative to revenue, Effective tax rate and tax burden.

Regarding relative positioning, Organo combines above-benchmark operating profitability with a conservative equity-funded balance sheet, characteristics supportive of resilience in a project-engineering manufacturer. Relative to a typical capital-intensive manufacturer, PPE intensity is modest at 10.2% of total assets, but the company carries a more pronounced receivables-driven working-capital burden. Its principal relative strength is high-margin water-treatment engineering capability; its principal relative weakness is the recent compression in project profitability and slower cash conversion.